Literature DB >> 21507184

Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study.

Kazumasa Matsumoto1, Giacomo Novara, Amit Gupta, Vitaly Margulis, Thomas J Walton, Marco Roscigno, Casey Ng, Eiji Kikuchi, Richard Zigeuner, Wassim Kassouf, Hans-Martin Fritsche, Vincenzo Ficarra, Guido Martignoni, Stefan Tritschler, Joaquin Carballido Rodriguez, Christian Seitz, Alon Weizer, Mesut Remzi, Jay D Raman, Christian Bolenz, Karim Bensalah, Theresa M Koppie, Pierre I Karakiewicz, Christopher G Wood, Francesco Montorsi, Masatsugu Iwamura, Shahrokh F Shariat.   

Abstract

OBJECTIVE: •To assess the impact of differences in ethnicity on clinico-pathological characteristics and outcomes of patients with upper urinary tract urothelial carcinoma (UTUC) in a large multi-center series of patients treated with radical nephroureterectomy (RNU).
MATERIALS AND METHODS: •We retrospectively collected the data of 2163 patients treated with RNU at 20 academic centres in America, Asia, and Europe. •Univariable and multivariable Cox regression models addressed recurrence-free survival (RFS) and cancer-specific survival (CSS).
RESULTS: •In all, 1794 (83%) patients were Caucasian and 369 (17%) were Japanese. All the main clinical and pathological features were significantly different between the two ethnicities. •The median follow-up of the whole cohort was 36 months. At last follow-up, 554 patients (26%) developed disease recurrence and 461 (21%) were dead from UTUC. •The 5-year RFS and CSS estimates were 71.5% and 74.2%, respectively, for Caucasian patients compared with 68.8% and 75.4%, respectively, for Japanese patients. •On univariable Cox regression analyses, ethnicity was not significantly associated with either RFS (P= 0.231) or CSS (P= 0.752). •On multivariable Cox regression analyses that adjusted for the effects of age, gender, surgical type, T stage, grade, tumour architecture, presence of concomitant carcinoma in situ, lymphovascular invasion, tumour necrosis, and lymph node status, ethnicity was not associated with either RFS (hazard ratio [HR] 1.1; P= 0.447) or CSS (HR 1.0; P= 0.908).
CONCLUSIONS: •There were major differences in the clinico-pathological characteristics of Caucasian and Japanese patients. •However, RFS and CSS probabilities were not affected by ethnicity and race was not an independent predictor of either recurrence or cancer-related death.
© 2011 THE AUTHORS; BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2011        PMID: 21507184     DOI: 10.1111/j.1464-410X.2011.10188.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  17 in total

Review 1.  Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.

Authors:  Aurélie Mbeutcha; Morgan Rouprêt; Ashish M Kamat; Pierre I Karakiewicz; Nathan Lawrentschuk; Giacomo Novara; Jay D Raman; Christian Seitz; Evanguelos Xylinas; Shahrokh F Shariat
Journal:  World J Urol       Date:  2016-04-21       Impact factor: 4.226

Review 2.  Prognostic factors for upper urinary tract urothelial carcinoma.

Authors:  Thomas F Chromecki; Karim Bensalah; Mesut Remzi; Grégory Verhoest; Eugene K Cha; Douglas S Scherr; Giacomo Novara; Pierre I Karakiewicz; Shahrokh F Shariat
Journal:  Nat Rev Urol       Date:  2011-07-05       Impact factor: 14.432

3.  Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients.

Authors:  Mihai Dorin Vartolomei; Shoji Kimura; Matteo Ferro; Liliana Vartolomei; Beat Foerster; Mohammad Abufaraj; Shahrokh F Shariat
Journal:  World J Urol       Date:  2018-02-21       Impact factor: 4.226

4.  Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.

Authors:  Tohru Nakagawa; Yoshimitsu Komemushi; Taketo Kawai; Masafumi Otsuka; Jimpei Miyakawa; Yukari Uemura; Atsushi Kanatani; Satoru Taguchi; Akihiro Naito; Motofumi Suzuki; Hiroaki Nishimatsu; Yoshikazu Hirano; Yoshinori Tanaka; Akihiko Matsumoto; Hideyo Miyazaki; Tetsuya Fujimura; Hiroshi Fukuhara; Haruki Kume; Yasuhiko Igawa; Yukio Homma
Journal:  World J Urol       Date:  2017-04-10       Impact factor: 4.226

5.  Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma.

Authors:  Shigeru Sakano; Hideyasu Matsuyama; Yoriaki Kamiryo; Shigeaki Hayashida; Norio Yamamoto; Yoshitaka Kaneda; Takahito Nasu; Yoshikazu Baba; Tomoyuki Shimabukuro; Akinobu Suga; Mitsutaka Yamamoto; Akihiko Aoki; Kimio Takai; Satoru Yoshihiro; Kazuo Oba
Journal:  Int J Clin Oncol       Date:  2014-06-27       Impact factor: 3.402

Review 6.  Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).

Authors:  Francesco Soria; Shahrokh F Shariat; Seth P Lerner; Hans-Martin Fritsche; Michael Rink; Wassim Kassouf; Philippe E Spiess; Yair Lotan; Dingwei Ye; Mario I Fernández; Eiji Kikuchi; Daher C Chade; Marko Babjuk; Arthur P Grollman; George N Thalmann
Journal:  World J Urol       Date:  2016-09-07       Impact factor: 4.226

7.  A retrospective analysis of incidence and its associated risk factors of upper urinary tract recurrence following radical cystectomy for bladder cancer with transitional cell carcinoma: the significance of local pelvic recurrence and positive lymph node.

Authors:  Sung Han Kim; Hyung-Kook Yang; Jung Hoon Lee; Eun-Sik Lee
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

Review 8.  Predictive models and prognostic factors for upper tract urothelial carcinoma: a comprehensive review of the literature.

Authors:  Aurélie Mbeutcha; Romain Mathieu; Morgan Rouprêt; Kilian M Gust; Alberto Briganti; Pierre I Karakiewicz; Shahrokh F Shariat
Journal:  Transl Androl Urol       Date:  2016-10

9.  Prognostic significance of urothelial carcinoma with divergent differentiation in upper urinary tract after radical nephroureterectomy without metastatic diseases: A retrospective cohort study.

Authors:  Chuan Qin; En-Li Liang; Zhi-Yong Du; Xiao-Yu Qiu; Gang Tang; Fei-Ran Chen; Bo Zhang; Da-Wei Tian; Hai-Long Hu; Chang-Li Wu
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

Review 10.  Risk stratification for upper tract urinary carcinoma.

Authors:  Daniel Benamran; Thomas Seisen; Elias Naoum; Christophe Vaessen; Jérome Parra; Pierre Mozer; Shahrokh F Shariat; Morgan Rouprêt
Journal:  Transl Androl Urol       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.